Skip to Main Content
LuminUltra
EnglishFrançais简体中文
LuminUltra Headquarters

#MadeInCanada: How COVID-19 Shaped Our Business

It has been one year since Canadian Prime Minister, Justin Trudeau announced that LuminUltra would be supplying the federal government with reagent for 25 million COVID-19 clinical diagnostic tests. Having now fulfilled our commitment, we wanted to take this opportunity to reflect on the past year and what it’s meant for our LuminUltra team.

When we started 2020, we were a global biotechnology leader developing rapid, portable, and accurate microbial monitoring solutions focused on the water sector. Today, we’ve expanded our product line and moved into the clinical diagnostic space. This has been a year of tremendous growth for our company and immense pride for the role we’ve been able to play in helping Canadians and countries across the globe fight the pandemic.

March

  • Early in March Source Molecular, now a LuminUltra company, developed, validated, ISO certified, and made available a COVID-19 wastewater testing service. They were the first environmental lab to globally get in the ring.
  • We launched our COVID-19 response plan to keep our employees safe, including new remote work policies and health and safety best practices for our on-site staff.
  • The Canadian Prime Minister, Justin Trudeau, issues a call-to-action to Canadian industry to support the fight against COVID-19. Our President & CEO, Pat Whalen, responds within minutes, kicking off discussions with the Public Health Agency of Canada (PHAC).

April

  • Prime Minister Trudeau publicly announces the role we’re playing, delivering tests across Canada, in his daily COVID-19 briefing.

August

  • Our COVID-19 clinical assay is completed.

September

  • LuminUltra has delivered 10 million tests to PHAC.
  • Our first shipment departs from LuminUltra’s brand new Canadian facility — constructed in under four months to meet the demand.

October

November

  • Health Canada grants Interim Order for our made-in-Canada COVID-19 clinical solution, giving governments and businesses across Canada the tools they need to deliver a high volume of the most accurate COVID-19 test results possible in under two hours.
  • LuminUltra announces the acquisition of Source Molecular Corporation, a leader in lab-based testing solutions for microbial source tracking of pathogens including SARS-CoV-2. With this acquisition, customers around the world can now choose to analyze samples remotely via mail-in service to Source Molecular, or rapidly onsite using LuminUltra’s gold standard GeneCount® qPCR testing kits.

January

  • On Jan. 4 we welcomed our 100th new team member since the start of 2020.

February

March

  • 25 million worth of reagents are delivered to PHAC, fulfilling our agreement.

Our core purpose — to create peace of mind so we can all work, live, and play with confidence — remains at the forefront of our efforts as we continue to develop solutions that can help keep our communities safe. LuminUltra’s journey over the past 26 years has been an exciting one, and we look forward to what’s to come next.


LuminUltra Team

Founded in 1995, LuminUltra is a molecular biology diagnostic testing company headquartered in Canada with operations in 6 countries. It is widely recognized globally as a leader in developing tests and reagents for environmental, industrial, and diagnostic monitoring applications and was a key supplier of COVID-19 diagnostic testing reagents to the Government of Canada.

Dozens of Fortune 500 customers across more than 80 countries trust LuminUltra’s technology, production reliability and history of customer service excellence to deliver their essential services in a safe state.

Related Posts

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now